{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320941204992.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/sj.onc.1206556"}},{"identifier":{"@type":"URI","@value":"https://www.nature.com/articles/1206556.pdf"}},{"identifier":{"@type":"URI","@value":"https://www.nature.com/articles/1206556"}},{"identifier":{"@type":"NAID","@value":"30013807738"}}],"dc:title":[{"@value":"Epstein–Barr virus and oncogenesis: from latent genes to tumours"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320941204992","@type":"Researcher","foaf:name":[{"@value":"Lawrence S Young"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320941204993","@type":"Researcher","foaf:name":[{"@value":"Paul G Murray"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09509232"},{"@type":"EISSN","@value":"14765594"}],"prism:publicationName":[{"@value":"Oncogene"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2003-08-11","prism:volume":"22","prism:number":"33","prism:startingPage":"5108","prism:endingPage":"5121"},"reviewed":"false","dc:rights":["https://www.springer.com/tdm","https://www.springer.com/tdm"],"url":[{"@id":"https://www.nature.com/articles/1206556.pdf"},{"@id":"https://www.nature.com/articles/1206556"}],"createdAt":"2003-08-11","modifiedAt":"2022-03-22","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050294045370702976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens"}]},{"@id":"https://cir.nii.ac.jp/crid/1050574201775462784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002220694872320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epstein-Barr Virus (EBV)-associated Gastric Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004231517536768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pathogenesis and FDG-PET/CT findings of Epstein–Barr virus-related lymphoid neoplasms"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235571454208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV inf"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693660029568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Downregulation of MicroRNA-200 in EBV-Associated Gastric Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285704947837312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Role of latent membrane protein 1 in chronic active Epstein–Barr virus infection‐derived T/NK‐cell proliferation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285705268481280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Modes of infection and oncogenesis by the Epstein–Barr virus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710503370368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinicopathological analysis of 12 patients with Epstein–Barr virus‐positive primary intestinal T/natural killer‐cell lymphoma (EBV<sup>+</sup> ITNKL)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298339731731712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epstein-Barr Virus Enhances Cancer-Specific Aberrant Splicing of TSG101 Pre-mRNA"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565164614522112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Switching of EBV cycles between latent and lytic states"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168088668288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185942071040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568619438622336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848664372997888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Herpesviral microRNAs in Cellular Metabolism and Immune Responses"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204705068544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Tumor Microenvironment and RIG-I Signaling Molecules in Epstein Barr Virus-Positive and -Negative Classical Hodgkin Lymphoma of the Elderly"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205033148160","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"EBV関連B細胞リンパ腫を合併したangioimmunoblastic T-cell lymphoma"},{"@language":"en","@value":"Angioimmunoblastic T-cell lymphoma complicated with EBV-associated B-cell lymphoma"},{"@value":"症例 EBV関連B細胞リンパ腫を合併したangioimmunoblastic T-cell lymphoma"},{"@language":"ja-Kana","@value":"ショウレイ EBV カンレン B サイボウ リンパ シュ オ ガッペイ シタ angioimmunoblastic T cell lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950399742674816","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Tumour-associated antigens : considerations for their use in tumour immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950400953885056","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/sj.onc.1206556"},{"@type":"CIA","@value":"30013807738"},{"@type":"CROSSREF","@value":"10.3390/v4123420_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.1007/s12149-017-1180-5_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.1111/j.1365-2559.2011.03976.x_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.3960/jslrt.54.75_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.1002/cam4.256_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.1002/rmv.1786_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.1111/his.13172_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.18632/oncotarget.10322_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.3390/ijms23052516_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.1002/rmv.1780_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.1111/all.12410_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.1128/jvi.03639-14_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.3389/fimmu.2020.00367_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.3389/fmicb.2017.01318_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.1158/0008-5472.can-09-4620_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"},{"@type":"CROSSREF","@value":"10.1186/s12885-021-08397-0_references_DOI_TVLa9oreUo3Ml13HjTE8Ex27RnN"}]}